Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.84%	21.102	$
VOD	-0.31%	15.96	$
BTI	-0.87%	56.21	$
BP	-0.85%	44.76	$
AZN	0.9%	165.98	$
RYCEF	-1.23%	20.25	$
RBGPF	0%	68.56	$
RIO	2.97%	105.3	$
GSK	0.86%	52.41	$
NGG	-1.08%	79.76	$
RELX	1.48%	35.91	$
CMSD	-0.67%	20.98	$
BCE	-0.3%	23.71	$
BCC	0.85%	82.47	$
JRI	-0.24%	12.38	$

Featured

Former cricket captains appeal to Pakistan over Khan health care

A group of 21 former international cricket captains, including India's Sunil Gavaskar and Kapil Dev, signed a letter to Pakistan's government Sunday regarding the health care of jailed former prime minister Imran Khan.

'Keep up the spirit': Indonesian teenage 'Superman' joins wildfire fight

Dressed as his favourite superhero, Indonesian teenager Rudiyansah walks along a charred landscape, helping douse wildfires that have razed large parts of Borneo island.

Last news

Bitter church row divides Armenia ahead of elections

Walking through the grounds of Armenia's most sacred church, 37-year-old worshipper Nara Sargsyan spoke in hushed tones as she criticised her government's attacks on the clergy.

Malaysia PM says not opposed to fugitive financier's bid for pardon

Malaysia will not oppose a bid by a fugitive businessman involved in the massive 1MDB corruption scandal to seek a pardon from US President Donald Trump, Prime Minister Anwar Ibrahim said Friday.

Letter to the Shareholders

LAKEWOOD, CO / ACCESS Newswire / May 15, 2026 / Kultura Brands, Inc. (OTCID:LTNC) ("Kultura Brands," "Kultura," or the "Company"), formerly known as Labor Smart INC., a publicly traded consumer products and lifestyle platform focused on scaling culture-driven beverage brands.

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate

VANCOUVER, BC / ACCESS Newswire / May 15, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has advanced its Chemistry, Manufacturing and Controls ("CMC") development program through the initiation of analytical method validation activities for assay, related substances, and residual solvents for A83B4C63, the active pharmaceutical ingredient ("API") for Onco's exclusively-licensed PNKP Inhibitor Technology, ONC010. These validation activities are designed to ensure the Company can consistently measure what is in the drug, confirm it meets quality standards, and demonstrate that manufacturing is reliable, all of which are important steps before a program can move toward future clinical trials.

Luvu Brands Reports Strong Q3 FY26 Results with 12% Revenue Growth, Margin Expansion, and Improved Profitability Driven by Disciplined Cost Management

ATLANTA, GA / ACCESS Newswire / May 15, 2026 / Luvu Brands, Inc. (OTCQB:LUVU), a U.S.-based manufacturer of lifestyle, wellness, and comfort products, today announced financial results for its third fiscal quarter ended March 31, 2026. The Company delivered meaningful improvements in revenue, profitability, and cash generation, reflecting continued execution of its cost optimization strategy and operational discipline.

Ensysce Biosciences Reports First Quarter 2026 Financial Results

~ IRB Approval Secured for PF614-MPAR-102 Part 3 ~~ Clinical Peer-Reviewed Data Published for First Overdose Protected Opioid PF614-MPAR®; Patent Estate Expanded ~~ Company Launches Formal Review of Strategic Alternatives ~

Havertys Furniture Second Quarter 2026 Cash Dividend

ATLANTA, GA / ACCESS Newswire / May 15, 2026 / Haverty Furniture Companies, Inc. (NYSE:HVT)(NYSE:HVT.A) ("Havertys" or the "Company") today announced that its Board of Directors declared a cash dividend to be paid on the outstanding shares of the two classes of $1 par value common stock of the company at a rate of $0.33 per share on the common stock and $0.31 per share on the Class A common stock. The dividend is payable on June 16, 2026, to stockholders of record at the close of business on June 1, 2026. Havertys has paid a cash dividend each year since 1935.

Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026

TAMPA, FL / ACCESS Newswire / May 15, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced that it will report financial results for the first quarter of 2026 on Tuesday, May 19, 2026.

IDLife Strengthens Scientific Leadership with Appointment of Dr. Michael Hartman, PhD, as Chair of Scientific & Medical Advisory Board

Appointment Signals Continued Expansion of IDLife's Science, Product Innovation, and Personalized Nutrition Platform

EHDS Readiness Shifts from EU Policy to Provider Budget and Vendor Accountability

Black Book Research's Pre-HIMSS26 Europe study of 881 healthcare leaders across 14 countries finds European Health Data Space readiness is now a provider funding, vendor accountability, and data execution challenge

NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering

SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses and their variants cannot escape, today announced it has entered into a securities purchase agreement with a single fundamental institutional investor for the purchase and sale of 1,333,334 million common shares (or pre-funded warrants in lieu thereof), together with accompanying warrants to purchase 1,333,334 common shares for gross proceeds of approximately US$2 million in a registered direct offering (the "Offering"). The common shares are being sold in combination with an accompanying full warrant (with each whole warrant being exercisable into one common share of the Company). Each whole warrant has an exercise price of US$1.75 per share and will expire three years from the date of issuance.

NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II

SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2026 with the Securities and Exchange Commission (SEC) on Thursday, May 14, 2026. The report can be accessed at the SEC website by searching for the Company (https://www.sec.gov/edgar/browse/?CIK=1379006&owner=exclude) .

InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 15

InterContinental Hotels Group PLC (the "Company")Purchase of own shares

Afghanistan's water crisis worsened last year: UN report

Afghanistan's water crisis worsened in 2025, the United Nations said in a report, with drought nearly doubling compared to the year before.

US jury awards $49.5 mn damages to Boeing 737 MAX victim's family

A US jury awarded $49.5 million in damages on Wednesday to the family of a 24-year-old American who perished in a 2019 Boeing 737 MAX crash.

South Africa court clears way for Zuma's arms graft trial

A South African court ruled Thursday that a long-running arms deal corruption case against former president Jacob Zuma and French defence giant Thales can proceed, rejecting bids to delay the trial.

Ex-Philippine drug war enforcer flees Senate refuge

The chief enforcer of former Philippine president Rodrigo Duterte's deadly drug war has fled the Senate, where he had sought refuge this week to escape arrest for crimes against humanity, the chamber's president said on Thursday.

Japan takes 'half step' toward fixing slow retrial system

Japanese policymakers have approved a proposal to reduce the power of prosecutors to thwart a process for exonerating potential victims of wrongful convictions, following an outcry over the country's retrial system.

Six hantavirus cruise passengers head to Australia

Six passengers who sailed on a hantavirus-affected cruise will fly to Australia from the Netherlands on Thursday while dressed in full protective gear, the Australian government said.

US court suspends sanctions on UN expert on Palestinians

A US judge on Wednesday imposed a temporary injunction on sanctions imposed last year by Washington on a United Nations expert on the occupied Palestinian territories.

Ethical Artform of Perfumery Remixes Displayed in NYC, Berlin and London

Naked Ghosts, an art gallery and store in Manhattan's West Village, is pleased to introduce two scent sculptures, Augmented Reality and F*** The Fluff.

374Water Reports First Quarter 2026 Financial Results; Gross Margins Expands Year-Over-Year as Company Advances Contracted Deployments, Waste Destruction Services Platform, and Strategic Partnerships

Recurring Revenue Platform Takes Shape as Contracted Operations Scale Across Municipal, Federal, and Industrial Markets

Stolon Introduces the Restaurant Industry's First Hand Cut Seed Oil Free Fry Platform

Crafted for Performance Chefs. Loved by Demanding Guests.

Newsmax Announces First Quarter 2026 Financial Results

Company Reports Quarterly Revenues of $51.7 million, a 14.0% Year-Over-Year IncreaseBroadcast Revenues Increase to $43.7 million, a 20.8% Increase Year-Over-YearCompany Reaffirms Full-Year 2026 Revenue Guidance, Representing Accelerated Year-Over-Year Growth of 13% at the Midpoint

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2026.

Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

Highlights:WellCare Today brings established RPM, RTM and CCM infrastructure with wearable technology integrations and connected monitoring solutionsCombination expected to integrate Wellgistics Health recently announced MSO initiative with Kare Clinicals and its network of 6,500+ independent pharmaciesProposed platform designed to enhance patient engagement, medication adherence, remote monitoring and longitudinal care coordinationProposed transaction valued at approximately $15 millionStrategic initiative intended to create additional clinical revenue opportunities for participating pharmacies and providers

CMS Hemp Program Insiders Admit Bypassing FDA Safety Standards for a Potential $34.5 Billion Medicare Payday

BEI Participants Publicly Discuss "Bypassing" FDA Pathway as Federal Court Weighs Legality of CMS Cannabinoid ProgramOn-Camera Statements From CMS Cannabinoid Program Participants Raise New Questions About Scientific Standards, Commercialization and Federal Authority

ALYZE Prepares to Open Utah's First Facility Where Your Gym, Doctor, Lab, and Recovery are All Under One Roof

The Bountiful flagship brings together comprehensive diagnostics, functional medicine, luxury fitness, and full recovery services into one coordinated membership, giving Utah professionals access to a level of integrated health care that has never existed in the consumer market

Hippocratic Cancer Research Foundation Announces Two Signature Chicago Fundraising Events: "Sail and Soiree" Fashion Show and "Golden Hour for Good" Rooftop Party

HCRF will bring together Chicago's philanthropic, medical, civic, and business communities for two June 2026 events supporting innovative cancer research at Northwestern University's Robert H. Lurie Comprehensive Cancer Center.

Pearl Planner by David's Bridal Expands Agentic AI Features with New Free Budgeting Engine, Removing Financial Guesswork out of Wedding Planning

World's Leading AI-Powered Wedding Planning Platform, Pearl Planner by David's, Newest Feature Turns Budgeting into Actionable Clarity Through Dynamic AI

Trustpoint Xposure Establishes Itself as the Definitive Authority on AEO, The Discipline Reshaping How Brands Are Found, Trusted, and Recommended by AI

As AI platforms replace traditional search for high-value professional discovery, Trustpoint Xposure leads the industry in helping brands become the single answer ChatGPT, Gemini, Claude, and Perplexity recommend

The Data-Ready Hospital: Europe's EHR Vendors Face the Data Valorisation Reality Check

Black Book Research survey of 662 healthcare IT leaders across eight European EMR markets finds post-go-live data-value execution separates top-performing vendors from vendors that sell data transformation better than they deliver it in 2026

Arizona Tribune - Boulevard (English)